Luteinizing Hormone-releasing Hormone Antagonists in Gynecology
Author:
Engel J. B.,Diedrich K.
Reference59 articles.
1. Adamson G.D. and Pasta D.J. (1994). Surgical treatment of endometriosis-associated infertility: a meta-analysis compared with survival analysis. Am J Obstet Gynecol, 171, 1488–1505.
2. Akman M.A., Erden H.F., Tosun S.B. et al. (2001). Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor respon-ders: results of a prospective randomized trial. Hum Reprod, 16, 868–870.
3. Al-Inany H. and Aboulghar M. (2002). GnRH antagonist in assisted reproduction: a Cochrane review. Hum Reprod, 17, 874–885.
4. Albano C, Felberbaum R.E., Smitz J. et al. (2000). Ovarian stimulation with HMG: results of a prospective randomised phase III European study comparing the luteinizing-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. Hum Reprod, 15, 526–531.
5. Ayala R.A., Meza E., Cervera A.R. et al. (1995). Effect of insulfated nafarelin (D-Nal-GnRH) upon uterine leiomyomata. Arch Med Res, 26, 523–526.